CardioVascular BioTherapeutics Signs Agreement with Kendle for Phase II Clinical Trial.

Business Wire › September 07, 2006

Linked as:

Extract

CardioVascular BioTherapeutics Signs Agreement with Kendle for Phase II Clinical Trial.

LAS VEGAS -- CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced it has signed a master service agreement with leading global clinical research organization (CRO) Kendle (NASDAQ: KNDL...

See the full content of this document

Sponsored links

ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Language

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company

Other documents:

Agency Information Collection Activities Proposals Submissions and Approvals | too young to rob? nah. | Gerlach, Eileen | Lesatz, Matthew J. | Sentencia nº 343 de Consiglio di Stato, January 20, 2010 | Sentencia nº 2448 de Consiglio di Stato May 31 2010 | Sentencia nº 6103 de Consiglio di Stato November 18 2008 | Sentencia de Cour de cassation, January 11, 2011 (caso Cour de cassation, cri...